Nivolumab + Platinum-Doublet Chemotherapy vs Chemotherapy as Neoadjuvant Treatment for Resectable (IB–IIIA) Non-Small Cell Lung Cancer in the Phase 3 CheckMate 816 Trial
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.